Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende Patientenratgeber
Erweiterte Suche
Anmelden
nach oben
Current Nutrition Reports
Erschienen in:

13.10.2022 | Cancer (RA Murphy, Section Editor)

The Ketogenic Diet: Considerations for Cancer Survivorship

verfasst von: Cara Miller, Karina Austin, Lawren Fischer, Eleah Stringer, Satnam Sidhu

Erschienen in: Current Nutrition Reports | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

This article aims to evaluate the current practice of the ketogenic diet (KD) in oncology by discussing feasibility, impact on quality of life, and implications for dietetic practice. Articles discussed were selected based on an adult oncology population with emphasis on publications from the last 5 years.

Recent Findings

There is a paucity of randomized prospective trials and articles reviewed were heterogeneous in nature, limiting the ability to draw conclusions about the KDs role in cancer care and survivorship. Despite the lack of evidence, patients with cancer are interested in KD. The authors highlight barriers to supporting implementation of KD and recommend the inclusion of a registered dietitian with experience in KD to ensure safety and support the nutrition goals of patients with cancer.

Summary

Thorough, well-designed randomized control trials are needed to elucidate the potential advantages of this diet therapy in cancer care and survivorship.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Halpern MT, McCabe MS, Burg MA. The cancer survivorship journey: models of care, disparities, barriers, and future directions. Am Soc Clin Oncol Educ Book. 2016;36:231–9.CrossRef
2.
Anderson JC, Mattar SG, Greenway FL, Lindquist RJ. Measuring ketone bodies for the monitoring of pathologic and therapeutic ketosis. Obes Sci Pract. 2021;7(5):646–56.CrossRef
3.
4.
Allen BG, Bhatia SK, Anderson CM, Eichenberger-Gilmore J, Sibenaller ZA, Mapuskar KA, et al. Ketogenic diets as an adjuvant cancer therapy: history and potential mechanism. Redox Biol. 2014;2:963–70.CrossRef
5.
Kossoff EH, Zupec-Kania BA, Auvin S, Ballaban-Gil KR, Christina Bergqvist AG, Blackford R, et al. Optimal clinical management of children receiving dietary therapies for epilepsy: updated recommendations of the international ketogenic diet study group. Epilepsia Open. 2018;3(2):175–92.CrossRef
6.
Dyson P. Low carbohydrate diets and type 2 diabetes: what is the latest evidence? Diabetes Ther. 2015;6(4):411–24.CrossRef
7.
Oliveira CLP, Mattingly S, Schirrmacher R, Sawyer MB, Fine EJ, Prado CM. A nutritional perspective of ketogenic diet in cancer: a narrative review. J Acad Nutr Diet. 2018;118(4):668–88.CrossRef
8.
Hu T, Yao L, Reynolds K, Whelton PK, Niu T, Li S, et al. The effects of a low-carbohydrate diet vs. a low-fat diet on novel cardiovascular risk factors: a randomized controlled trial. Nutrients 2015;7(9):7978–7994.
9.
Seyfried TN, Shivane AG, Kalamian M, Maroon JC, Mukherjee P, Zuccoli G. Ketogenic metabolic therapy, without chemo or radiation, for the long-term management of IDH1-mutant glioblastoma: an 80-month follow-up case report. Front Nutr. 2021;8.
10.
Maroon JC, Seyfried TN, Donohue JP, Bost J. The role of metabolic therapy in treating glioblastoma multiforme. Surg Neurol Int. 2015;16(6):61–7806.155259. eCollection 2015.
11.
Zuccoli G, Marcello N, Pisanello A, Servadei F, Vaccaro S, Mukherjee P, et al. Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: case report. Nutr Metab (Lond). 2010;22(7):33–33.CrossRef
12.
Schwartz K, Chang HT, Nikolai M, Pernicone J, Rhee S, Olson K, et al. Treatment of glioma patients with ketogenic diets: report of two cases treated with an IRB-approved energy-restricted ketogenic diet protocol and review of the literature. Cancer Metab 2015;25(3):3–1. eCollection 2015.
13.
• Klassen PN, Goldenberg BA, Lambert P, Vagianos K, Kim CA. Ketogenic and low-sugar diets for patients with cancer: perceptions and practices of medical oncologists in Canada. Support Care Cancer. 2020;28(11):5243–9. These survey results provide insight into the perception of the KD and low-sugar diets in the oncology setting among 57 medical oncologists across Canada. The questions were developed by oncology dietitians to assess practitioner experience with patient questions, perceptions and practices of the diet, and interest in continuing learning in this area.CrossRef
14.
Hultin G. Cancer: The keto diet’s impact on cancer treatment. Today's Diet. 2019;14.
15.
16.
Phillips MCL, Murtagh DKJ, Sinha SK, Moon BG. Managing metastatic thymoma with metabolic and medical therapy: a case report. Front Oncol. 2020;10.
17.
Elsakka AMA, Bary MA, Abdelzaher E, Elnaggar M, Kalamian M, Mukherjee P, et al. Management of glioblastoma multiforme in a patient treated with ketogenic metabolic therapy and modified standard of care: a 24-month follow-up. Front Nutr. 2018;5.
18.
Klein P, Tyrlikova I, Zuccoli G, Tyrlik A, Maroon JC. Treatment of glioblastoma multiforme with “classic” 4:1 ketogenic diet total meal replacement. Cancer & Metabolism. 2020;8(1):24.CrossRef
19.
Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, et al. Long-term survival with glioblastoma multiforme. Brain. 2007;130(Pt 10):2596–606.CrossRef
20.
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987–96.CrossRef
21.
Martin-McGill KJ, Marson AG, Tudur Smith C, Jenkinson MD. The modified ketogenic diet in adults with glioblastoma: an evaluation of feasibility and deliverability within the national health service. Nutr Cancer. 2018;70(4):643–9.CrossRef
22.
Klement RJ, Bandyopadhyay PS, Champ CE, Walach H. Application of Bayesian evidence synthesis to modelling the effect of ketogenic therapy on survival of high grade glioma patients. Theor Biol Med Model. 2018;15(1):12-y.
23.
Augustus E, Granderson I, Rocke KD. The impact of a ketogenic dietary intervention on the quality of life of stage II and III cancer patients: a randomized controlled trial in the Caribbean. Nutr Cancer. 2021;73(9):1590–600.CrossRef
24.
Khodabakhshi A, Seyfried TN, Kalamian M, Beheshti M, Davoodi SH. Does a ketogenic diet have beneficial effects on quality of life, physical activity or biomarkers in patients with breast cancer: a randomized controlled clinical trial. Nutr J. 2020;19(1):87-y.
25.
•• Klement RJ, Champ CE, Kämmerer U, Koebrunner PS, Krage K, Schäfer G, et al. Impact of a ketogenic diet intervention during radiotherapy on body composition: III—final results of the KETOCOMP study for breast cancer patients. Breast Cancer Res. 2020;22(1):94. This prospective, non-randomized control phase I clinical trial examines the effects of a KD versus standard diet on body composition in patients with breast cancer undergoing radiotherapy. The study was well-designed with a larger sample size and included a control group following a standard diet. It should be noted that there are multiple papers written about this KETOCOMP study in various oncology populations (rectal and head and neck cancers) assessing a variety of outcomes (ie. quality of life, metabolic health) that will be noted by a double asterisk.CrossRef
26.
•• Klement RJ, Schäfer G, Sweeney RA. A ketogenic diet exerts beneficial effects on body composition of cancer patients during radiotherapy: an interim analysis of the KETOCOMP study. J Tradit Complement Med. 2020;10(3):180–7. This prospective, non-randomized control phase I clinical trial examines the effects of a KD versus standard diet on body composition in patients with breast cancer undergoing radiotherapy. The study was well-designed with a larger sample size and included a control group following a standard diet. It should be noted that there are multiple papers written about this KETOCOMP study in various oncology populations (rectal and head and neck cancers) assessing a variety of outcomes (ie. quality of life, metabolic health) that will be noted by a double asterisk.CrossRef
27.
•• Klement RJ, Weigel MM, Sweeney RA. A ketogenic diet consumed during radiotherapy improves several aspects of quality of life and metabolic health in women with breast cancer. Clin Nutr. 2021;40(6):4267–74. This prospective, non-randomized control phase I clinical trial examines the effects of a KD versus standard diet on body composition in patients with breast cancer undergoing radiotherapy. The study was well-designed with a larger sample size and included a control group following a standard diet. It should be noted that there are multiple papers written about this KETOCOMP study in various oncology populations (rectal and head and neck cancers) assessing a variety of outcomes (ie. quality of life, metabolic health) that will be noted by a double asterisk.
28.
•• Klement RJ, Sweeney RA. Impact of a ketogenic diet intervention during radiotherapy on body composition: I. Initial clinical experience with six prospectively studied patients. BMC Res Notes 2016;9:143. This prospective, non-randomized control phase I clinical trial examines the effects of a KD versus standard diet on body composition in patients with breast cancer undergoing radiotherapy. The study was well-designed with a larger sample size and included a control group following a standard diet. It should be noted that there are multiple papers written about this KETOCOMP study in various oncology populations (rectal and head and neck cancers) assessing a variety of outcomes (ie. quality of life, metabolic health) that will be noted by a double asterisk.
29.
van der Louw EJTM, Olieman JF, van den Bemt PMLA, Bromberg JEC, Oomen-de Hoop E, Neuteboom RF, et al. Ketogenic diet treatment as adjuvant to standard treatment of glioblastoma multiforme: a feasibility and safety study. Ther Adv Med Oncol. 2019;21(11):1758835919853958.
30.
•• Martin-McGill KJ, Marson AG, Tudur Smith C, Young B, Mills SJ, Cherry MG, et al. Ketogenic diets as an adjuvant therapy for glioblastoma (KEATING): a randomized, mixed methods, feasibility study. J Neurooncol. 2020;147(1):213–27. This single-center, prospective, randomized, pilot study included a qualitative component to determine the feasibility of KD trials for patients with glioblastomas. The study offers a randomized control trial design that can be replicated in the future for larger sample sizes and date collection. The study uses modified KD as an intervention which may be better tolerated, more feasible and more likely to meet nutrition needs in the oncology population.CrossRef
31.
Ma DC, Anderson CM, Rodman SN, Buranasudja V, McCormick ML, Davis A, et al. Ketogenic diet with concurrent chemoradiation in head and neck squamous cell carcinoma: preclinical and phase 1 trial results. Radiat Res. 2021;196(2):213–24.CrossRef
32.
•• Klement RJ, Meyer D, Kanzler S, Sweeney RA. Ketogenic diets consumed during radio-chemotherapy have beneficial effects on quality of life and metabolic health in patients with rectal cancer. Eur J Nutr. 2022;61(1):69–84. This prospective, non-randomized control phase I clinical trial examines the effects of a KD versus standard diet on body composition in patients with breast cancer undergoing radiotherapy. The study was well-designed with a larger sample size and included a control group following a standard diet. It should be noted that there are multiple papers written about this KETOCOMP study in various oncology populations (rectal and head and neck cancers) assessing a variety of outcomes (ie. quality of life, metabolic health) that will be noted by a double asterisk.
33.
Kämmerer U, Klement RJ, Joos FT, Sütterlin M, Reuss-Borst M. Low carb and ketogenic diets increase quality of life, physical performance, body composition, and metabolic health of women with breast cancer. Nutrients. 2021;13(3):1029. https://​doi.​org/​10.​3390/​nu13031029.CrossRef
34.
• Yang YF, Mattamel PB, Joseph T, Huang J, Chen Q, Akinwunmi BO, et al. Efficacy of low-carbohydrate ketogenic diet as an adjuvant cancer therapy: a systematic review and meta-analysis of randomized controlled trials. Nutrients. 2021;13(5):1388. https://​doi.​org/​10.​3390/​nu13051388. This systematic and meta-analysis review of randomized control trials based on KD as an adjuvant therapy on cancer patients analyzed the significance of KD and non-KD dietary interventions on body weight and various biochemical markers as well as adverse events in many different tumor sites. It is a very comprehensive and most up-to-date review.CrossRef
35.
Ok JH, Lee H, Chung HY, Lee SH, Choi EJ, Kang CM, et al. The potential use of a ketogenic diet in pancreatobiliary cancer patients after pancreatectomy. Anticancer Res. 2018;38(11):6519–27.CrossRef
36.
Schreck KC, Hsu FC, Berrington A, Henry-Barron B, Vizthum D, Blair L, et al. Feasibility and biological activity of a ketogenic/intermittent-fasting diet in patients with glioma. Neurology. 2021;97(9):e953–63.CrossRef
37.
Panhans CM, Gresham G, Amaral LJ, Hu J. Exploring the feasibility and effects of a ketogenic diet in patients with CNS malignancies: a retrospective case series. Front Neurosci. 2020;14.
38.
Tan-Shalaby JL, Carrick J, Edinger K, Genovese D, Liman AD, Passero VA, et al. Modified atkins diet in advanced malignancies - final results of a safety and feasibility trial within the Veterans Affairs Pittsburgh Healthcare System. Nutr Metab (Lond) 2016;13:52-y. eCollection 2016.
39.
Schmidt M, Pfetzer N, Schwab M, Strauss I, Kämmerer U. Effects of a ketogenic diet on the quality of life in 16 patients with advanced cancer: a pilot trial. Nutr Metab (Lond). 2011;8(1):54–54.CrossRef
40.
Klement RJ. The emerging role of ketogenic diets in cancer treatment. Curr Opin Clin Nutr Metab Care. 2019;22(2):129–34.CrossRef
41.
Sremanakova J, Sowerbutts AM, Burden S. A systematic review of the use of ketogenic diets in adult patients with cancer. J Hum Nutr Diet. 2018;31(6):793–802.CrossRef
42.
Cohen CW, Fontaine KR, Arend RC, Soleymani T, Gower BA. Favorable effects of a ketogenic diet on physical function, perceived energy, and food cravings in women with ovarian or endometrial cancer: a randomized, controlled trial. Nutrients. 2018;10(9):1187. https://​doi.​org/​10.​3390/​nu10091187.CrossRef
43.
Khodabakhshi A, Akbari ME, Mirzaei HR, Mehrad-Majd H, Kalamian M, Davoodi SH. Feasibility, safety, and beneficial effects of MCT-based ketogenic diet for breast cancer treatment: a randomized controlled trial study. Nutr Cancer. 2020;72(4):627–34.CrossRef
44.
Khodabakhshi A, Akbari ME, Mirzaei HR, Seyfried TN, Kalamian M, Davoodi SH. Effects of ketogenic metabolic therapy on patients with breast cancer: a randomized controlled clinical trial. Clin Nutr. 2021;40(3):751–8.CrossRef
45.
Tulipan J, Kofler B. Implementation of a low-carbohydrate diet improves the quality of life of cancer patients - an online survey. Front Nutr. 2021;11(8): 661253.CrossRef
46.
Rieger J, Bähr O, Maurer G,D., Hattingen E, Franz K, Brucker D, et al. ERGO: a pilot study of ketogenic diet in recurrent glioblastoma. Int J Oncol. 2014;44(6):1843–1852.
47.
Schwartz KA, Noel M, Nikolai M, Chang HT. Investigating the ketogenic diet as treatment for primary aggressive brain cancer: challenges and lessons learned. Front Nutr. 2018;5.
48.
Pasca L, De Giorgis V, Macasaet JA, Trentani C, Tagliabue A, Veggiotti P. The changing face of dietary therapy for epilepsy. Eur J Pediatr. 2016;175(10):1267–76.CrossRef
49.
50.
Voss M, Wagner M, von Mettenheim N, Harter PN, Wenger KJ, Franz K, et al. ERGO2: A prospective, randomized trial of calorie-restricted ketogenic diet and fasting in addition to reirradiation for malignant glioma. Int J Radiat Oncol Biol Phys. 2020;108(4):987–95.CrossRef
51.
Woodhouse C, Ward T, Gaskill-Shipley M, Chaudhary R. Feasibility of a modified atkins diet in glioma patients during radiation and its effect on radiation sensitization. Curr Oncol. 2019;26(4):e433–8.CrossRef
52.
Kirkham AA, King K, Joy AA, Pelletier AB, Mackey JR, Young K, et al. Rationale and design of the diet restriction and exercise-induced adaptations in metastatic breast cancer (DREAM) study: a 2-arm, parallel-group, phase II, randomized control trial of a short-term, calorie-restricted, and ketogenic diet plus exercise during intravenous chemotherapy versus usual care. BMC Cancer. 2021;21(1):1093.CrossRef
53.
Wang Y, Jing M, Jiang L, Jia Y, Ying E, Cao H, et al. Does a ketogenic diet as an adjuvant therapy for drug treatment enhance chemotherapy sensitivity and reduce target lesions in patients with locally recurrent or metastatic Her-2-negative breast cancer? Study protocol for a randomized controlled trial. Trials. 2020;21(1):487.CrossRef
54.
55.
56.
57.
World Cancer Research Fund/American Institute for Cancer Research. Diet, nutrition, physical activity and cancer: a global perspective a summary of the third expert report. Continuous Update Project Report 2018.
58.
Metadaten
Titel
The Ketogenic Diet: Considerations for Cancer Survivorship
verfasst von
Cara Miller
Karina Austin
Lawren Fischer
Eleah Stringer
Satnam Sidhu
Publikationsdatum
13.10.2022
Verlag
Springer US
Erschienen in
Current Nutrition Reports / Ausgabe 4/2022
Elektronische ISSN: 2161-3311
DOI
https://doi.org/10.1007/s13668-022-00439-8

Weitere Artikel der Ausgabe 4/2022

Improving Iodine Status in Lactating Women: What Works?

  • Open Access
  • Public Health Nutrition (KE Charlton, Section Editor)

Physical Activity and Breast Cancer Survival–Epidemiologic Evidence and Potential Biologic Mechanisms

  • Cancer (MF Leitzmann and T Kuhn, Section Editor)

Diet, Gut Microbiome, and Cognitive Decline

  • Nutrition and the Brain (J Nasser, Section Editor)

Therapeutic Potential of GLP-2 Analogs in Gastrointestinal Disorders: Current Knowledge, Nutritional Aspects, and Future Perspectives

  • Diabetes and Obesity (M Dalamaga and F Magkos, Section Editors)

Is Vitamin D Important in Anxiety or Depression? What Is the Truth?

  • Nutrition and the Brain (J Nasser, Section Editor)

The Endocannabinoid System and Eating Behaviours: a Review of the Current State of the Evidence

  • Open Access
  • Nutrition and the Brain (J Nasser, Section Editor)

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Verbände und Cremes gegen Dekubitus: „Wir wissen nicht, was sie bringen!“

Die Datenlage zur Wirksamkeit von Verbänden oder topischen Mitteln zur Prävention von Druckgeschwüren sei schlecht, so die Verfasser einer aktuellen Cochrane-Studie. Letztlich bleibe es unsicher, ob solche Maßnahmen den Betroffenen nutzen oder schaden.

Schützt das tägliche Glas Milch vor Darmkrebs?

Die Milch machts – sie bietet Frauen nach Daten einer großen Ernährungsanalyse den besten Darmkrebsschutz aller Lebensmittel, was am hohen Kalziumgehalt liegen dürfte. Am anderen Ende des Spektrums steht der Alkoholkonsum: Das Glas Wein am Abend ist eher ungünstig.

Vorsicht mit Glukokortikoiden bei Glomerulopathie

Auch niedrig dosierte Glukokortikoide zur Behandlung einer primären Glomerulopathie lassen offenbar die Infektionsgefahr steigen. In einer US-Studie hing das Risiko vor allem mit der kombinierten Anwendung von Immunsuppressiva zusammen.

KI-gestütztes Mammografiescreening überzeugt im Praxistest

Mit dem Einsatz künstlicher Intelligenz lässt sich die Detektionsrate im Mammografiescreening offenbar deutlich steigern. Mehr unnötige Zusatzuntersuchungen sind laut der Studie aus Deutschland nicht zu befürchten.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Jetzt 10 CME-Punkte sammeln

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise